Epinephrine Injector

Solicitation SPE2D2-26-R-0009 is a request for proposal issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain for the procurement of Epinephrine 0.3 MG/0.3 ML Injection Auto-Injectors in 2-count boxes. The contract is structured with a base year and two option years, with an estimated annual quantity of 473,905 boxes and a total duration not to exceed five years. This is a lowest price technically acceptable (LPTA) acquisition, where the award will be granted to the responsible offeror who meets all technical requirements and past performance standards while providing the lowest evaluated aggregate price. Proposals must be submitted electronically via the DIBBS portal by November 16, 2026, following an extension from the original November 2 deadline. Technical requirements mandate that all products be FDA approved with a Therapeutic Equivalence Code of A, unless all family group drugs are B rated, and manufactured in compliance with current Good Manufacturing Practices. Strict packaging and labeling standards apply, including a prohibition on glass bottles and a requirement for linear bar code labeling at the unit-of-use level conforming to GS1-128 or HIBC standards. Contractors must ensure delivery to multiple Prime Vendor distribution centers within 15 days of order completion and be ready to fill orders within 45 calendar days of award. The solicitation also incorporates various FAR and DFARS clauses regarding trade agreements, cybersecurity, and the Drug Supply Chain Security Act.